Skip to Content

Head & Neck-Post-Operative Radiation Therapy (IMRT) +/- Cetuximab

Objective

RTOG 0920 A Phase III Study of Post-Operative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

The purpose of this study is to compare the effects, good and/or bad, of radiation therapy alone with radiation therapy and cetuximab the cancer to find out which is better.  Patients will receive either radiation therapy alone OR radiation therapy and cetuximab.

Contact
Rebecca Denofer, RN, OCN at 802-747-1692
or rdenofer@rrmc.org

Rutland Regional Medical Center
160 Allen Street
Rutland, VT 05701
802.775.7111

Facebook YouTube LinkedIn Twitter